Title: Family Medicine – Dermatology: Introduction to Dermatology; Common Tumors Part 1 and Part 2
Faculty: O. Fred Miller, III, M.D., Michele S. Maroon, M.D.
Original Release Date: July 1, 2019 Expiration Date: July 1, 2022
TOPIC 1: Introduction – Essentials of Dermatology Diagnosis.
Upon completion of this session, the participant should be able to: COMP^
- Approach dermatologic disorders with a consistent and logical method.
- Interpret the role of “color” in the diagnosis of cutaneous lesions.
- Select the appropriate therapy for common disorders
TOPIC 2: Common Tumors in the Office Setting, Part I: Warts, Mollusca, Fibrous Tumors, Cutaneous Horns, Acanthomas.
Upon completion of this session, the participant should be able to: GL, COMP
- Devise a treatment plan for common tumors, which may include observation, biopsy, removal, and referral.
- Recognize the multiple cutaneous manifestations of warts and “wart-like” lesions and develop a stepwise treatment approach based on literature review and the British Association of Dermatology Treatment Guidelines.
TOPIC 3: Common Tumors in the Office Setting, Part II: Common Neoplasm of Head and Neck, Cysts, Vascular Tumors, Dermatofibroma, Keratoses, Lipoma, Soft Tissue Growths, Granulomas, Metastatic Carcinoma, Lymphoma.
Upon completion of this session, the participant should be able to: EBM, GL, COMP^
- Develop an approach to common dermal tumors, including most appropriate type of biopsy based on pathophysiology.
- Initiate systemic evaluation in setting of certain skin lesions that may be associated with underlying medical conditions.
- Outline and institute appropriate systemic evaluation for malignancy in setting of newly diagnosed extramammary Paget Disease as proposed by Mayo Clinic Guidelines.
- Demonstrate awareness of guidelines and implementation and/or appropriate referral for managing infantile hemangiomas as per the American Academy of Pediatrics.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.